Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 02 Jun 2027. The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions using a milestone-driven, biphasic award mechanism, R61/R33 Phased Innovation Award. Specifically, this NOFO solicits applications that will c…
Opportunity overview
- Project name
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)?
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 02 Jun 2027. The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions using a milestone-driven, biphasic award mechanism, R61/R33 Phased Innovation Award. Specifically, this NOFO solicits applications that will c…
Who is funding Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)?
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)?
The application deadline is 02 Jun 2027 00:00 (UTC).
Where will the Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) project take place?
The project location(s) are: United States.
How can I apply for Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.